Targeted inhibition of SCFSKP2 confers anti-tumor activities resulting in a survival benefit in osteosarcomaJichuan Wang, Bang H. Hoang|Oncogene|2024Cited by 20
Targeted inhibition of SCF <sup>SKP2</sup> confers anti-tumor activities resulting in a survival benefit in osteosarcomaJichuan Wang, Bang H. Hoang|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 1